6 completed, 1 unknown, 1 withdrawn. 8 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 6, Unknown 1, Withdrawn 1 |
Follow IPV: new trials by email Literature Review of IPV trials Research Report on IPV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants HRV PCV-free, IPV - Gastroenteritis | Phase 3 | Completed | GlaxoSmithKline | 400 | 2024-03-22 | 2025-10-22 |
| Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074) RotaTeq (V260), IPV - Prevention of Rotavirus Gastroenteritis in Infants and Children Caused by Serotypes G1, G2, G3, G4, and G9 | Phase 3 | Completed | Merck Sharp & Dohme LLC | 400 | 2020-08-25 | 2024-07-26 |
| A Study to Evaluate Immunogenicity of Intramuscular Full-Dose and Intradermal Fractional Dose of IPV IPV, f-IPV - Poliomyelitis | Phase 3 | Completed | Fidec Corporation | 773 | 2017-10-23 | 2023-07-21 |
| A Study to Evaluate Immunogenicity of Various Schedules of Inactivated Polio Vaccine IPV, f-IPV - Poliomyelitis | Phase 3 | Withdrawn | Fidec Corporation | 2017-07-01 | 2017-06-27 | |
| Assessment of Community Transmission of Sabin Type 2 Virus in Bangladesh tOPV, bOPV, IPV - Vaccine Virus Shedding | Phase 3 | Unknown | University of Virginia | 810 | 2015-04-01 | 2016-10-26 |
| Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine Infanrix+Hib™, Poliorix™ - Acellular Pertussis, Tetanus | Phase 3 | Completed | GlaxoSmithKline | 831 | 2011-10-01 | 2018-06-06 |
| Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines Synflorix, Tritanrix-HepB, Hiberix - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 756 | 2007-10-22 | 2019-01-14 |
| Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine Pneumococcal conjugate vaccine GSK1024850A, Prevenar, Tritanrix-HepB - Infections, Streptococcal | Phase 3 | Completed | GlaxoSmithKline | 806 | 2006-08-07 | 2018-12-07 |
Pneumococcal Infections (2) · Poliomyelitis (2) · Streptococcal Infections (2) · Diphtheria (1) · Gastroenteritis (1) · Haemophilus Infections (1) · Tetanus (1)
GlaxoSmithKline (4) · Fidec Corporation (2) · Merck Sharp & Dohme LLC (1) · University of Virginia (1)
China (3) · Philippines (2) · Poland (2) · Bangladesh (1) · Dominican Republic (1) · Panama (1)
K Zaman, MBBS, PhD (1) · Mami Taniuchi, PhD (1) · Stella Gutierrez, MD (1) · William A Petri, Jr., MD, PhD (1)
PMID 19325447, PMID 19325451, PMID 19325452, PMID 28693854, PMID 33284114, PMID 34932560, PMID 38509699